-
181
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
182
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
183
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
184
Correction: Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
185
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
186
Weal and woe of interleukin-18 in the T cell therapy of cancer
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
187
Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
188
Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
189
Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
190
Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
191
Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
192
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
193
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
194
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
195
Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
196
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
197
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
198
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
199
New developments in immunotherapy for SCLC
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
200
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article